Jun 22, 2026
AeroVironment Stock Dips as U.S.-Iran Peace Talks Continue

AeroVironment Inc (NASDAQ:AVAV) shares are sliding on Monday as defense stocks face pressure from progress in the U.S. Iran peace process and the new Chinese export restrictions aimed at U.S. defense end users. AeroVironment stock is testing lower boundaries. What’s…

Jun 22, 2026
Stock Of The Day: When Will Western Digital Reverse?

Western Digital Corp. (NASDAQ:WDC) is trading higher on Monday. The shares have gained about 30% in one week. But they may be on the verge of a reversal and are extremely overbought. This is why Western Digital is the Stock…

Jun 22, 2026
Netflix Stock Sinks To 52-Week Low — What’s Going On?

Netflix Inc. (NASDAQ:NFLX) stock fell Monday, hitting a fresh 52-week low. The downward movement follows mounting anxiety among market participants regarding the streaming company’s recent failed media acquisitions. Acquisition Anxiety Drags Shares The recent decline builds on pressure from June…

Jun 22, 2026
What’s Going On With T1 Energy Stock Monday?

T1 Energy Inc. (NYSE:TE) stock is drawing attention from traders following multiple operational and market updates over recent sessions. Bernstein Initiates Market Perform Rating On T1 Energy On Wednesday, Bernstein initiated coverage on T1 Energy with a Market Perform rating…

Jun 22, 2026
HIVE Stock Surges After Groundbreaking AI Project In Paraguay

HIVE Digital Technologies Ltd (NASDAQ:HIVE) shares are soaring Monday after the company announced the completion of its AI research initiative using its GPU cluster in Asunción, Paraguay, in partnership with Columbia University. Here’s what you need to know. HIVE Digital…

Jun 22, 2026
Nokia Stock Gains As Google Cloud Partnership Adds Gemini AI Agents

Nokia Oyj (NYSE:NOK) shares are trading higher on Monday after the company expanded its partnership with Google Cloud, part of Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL), to bring Gemini-powered AI agents into Nokia’s Assurance Center. • Nokia stock is surging to new heights…

Jun 22, 2026
Exelixis Provides ‘A Highly Defensive Investment Profile:’ Analyst

EExelixis Inc. NASDAQ: EXEL) on Monday reported final overall survival data from the Phase 3 STELLAR-303 trial. The data showed that the investigational combination of zanzalintinib and atezolizumab demonstrated a numerical overall survival benefit, but failed to achieve statistical significance…

Jun 22, 2026
Praxis’ Seizure Drug Move Towards Faster Development After Positive Trial Results

Praxis Precision Medicines Inc. (NASDAQ:PRAX) said on Monday that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to elsunersen (PRAX-222), its investigational therapy for seizures associated with SCN2A developmental and epileptic encephalopathy (SCN2A-DEE) caused by gain-of-function variants in…